首页> The Journal of dermatological treatment> Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

导出 LinkOut

翻译打印收藏纠错

第一作者： Guy,Shalom

第一单位： a Department of Dermatology and Venereology, Soroka Medical Center , Beer-Sheva , Israel.

作者： Guy,Shalom ^[1] ; Luigi,Naldi ^[2] ; Mark,Lebwohl ^[3] ; Arjen,Nikkels ^[4] ; Elke M G J,de Jong ^[5] ; Steven,Fakharzadeh ^[6] ; Kavitha G,Goyal ^[7] ; Bhaskar,Srivastava ^[7] ; Wayne,Langholff ^[6] ; Claudia,Galindo ^[6] ; Arnon D,Cohen ^[8]

作者单位： a Department of Dermatology and Venereology, Soroka Medical Center , Beer-Sheva , Israel. ^[1] b Department of Dermatology, Azienda Ospedaliera Papa Giovanni XXIII, Study Center of the Italian Group for Epidemiologic Research in Dermatology (GISED) , Bergamo , Italy. ^[2] c Icahn School of Medicine at Mount Sinai , New York, NY , USA. ^[3] d Liège University Hospital CHU , Liège , Belgium. ^[4] e Radboud University Medical Centre, and Radboud University Nijmegen , Nijmegen , The Netherlands. ^[5] f Janssen Research & Development, LLC , Horsham , PA , USA. ^[6] g Janssen Scientific Affairs, LLC , Horsham , PA , USA. ^[7] h Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev , Beer Sheva , Israel.;i Clalit Health Services , Tel Aviv , Israel. ^[8]

关键词 Biologics PSOLAR herpes zoster psoriasis tumor necrosis factor